Temozolomide trials for Colorectal cancer

All Temozolomide trials · All Colorectal cancer trials

Phase breakdown

Recruiting trials studying Temozolomide for Colorectal cancer

• 5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
  NCT04689347 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
  NCT03715933 · Phase: Phase 1 · Ages: 12 Years to 85 Years · Sex: All (male and female) · 36 locations
• Preoperative Chemoradiotherapy With CApecitabine and Temozolomide in MGMT Silenced, MSS, Locally Advanced RecTal Cancer
  NCT05136326 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
  NCT05691491 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 23 locations

Common questions

How many trials study Temozolomide for Colorectal cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.